SD HEALTHCARE
Recent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...
Cue Health to Sell 12 Million Shares in IPO
Cue Health will offer 12.5 million common shares for a range of $15 to $17 per share, according to its amended IPO.
Advanced BioMatrix Acquired for $15 Million
BIOTECH: San Diego Co. Joins BICO’s Bioprinting Business
Advanced BioMatrix, a San Diego biotech that creates products for 3D applications including cell cultivation, cell assays and bioprinting, was acquired by BICO Group AB (STO: BICO) for approximately $15 million.
Scientist.com Acquires InsideScientific
Scientist.com expands its offerings of "biotech as a service” (BaaS) platform
ARS Pharma Raises $55M
MEDICINE: Funding Backs Product Launch
ARS Pharmaceuticals, a pre-commercial pharmaceutical company, raised $55 million in Series D funding to back preparations for the launch of its lead product Neffy, an epinephrine nasal spray.
iBio to Grow Talent in S.D.
BIOTECH: Co. Develops Plant-Based Therapies
iBio, Inc. (NYSEA: IBIO), a company that produces plant-based antibodies for therapeutics and vaccines, has joined the growing number of life science companies choosing to expand their operations in San Diego.
Codex DNA Releases Full-Length Synthetic Genome for Highly Infectious SARS-CoV-2 Delta Variant
Codex DNA released full-length synthetic genome of COVID-19 Delta variant virus.
Cue Health Files for IPO
Cue Health filed an initial public offering on Sept. 1.
Poseida Therapeutics Announces FDA Clearance of Investigational New Drug Application
FDA clears the company's first fully allogeneic CAR-T product candidate for patients with relapsed/refractory multiple myeloma.
Advanced BioMatrix Acquired by BICO for $15M
San Diego-based Advanced BioMatrix acquired for $15 million.
NuVasive’s Q2 Earnings Up 45%
BIOTECH: Co. Increases Investment in R&D
San Diego medical device company, NuVasive (NASDAQ: NUVA) recorded $294.8 million in net sales for the second quarter 2021 — a 44.8% increase from the previous year’s same period.
BioSurplus in 3-Way Merger
BIOTECH: Co. Formed As One-Stop-Shop
Local life science company, BioSurplus, joined Massachusetts-based Biodirect and Boston Microscopes in a three-way merger to form Copia Scientific.
The Conrad Prebys Foundation Approves $1M Grant for Tri-City Hospital
Tri-City Medical Center is home to acclaimed emergency room-based programs in heart attack and stroke care.
INOVIO Gets Authorization for Phase 3 Trials of COVID-19 Vaccine Candidate
BIOTECH: Brazil’s Regulatory Agency Gives the Co. Green Light
INOVIO received authorization from Brazil's ANVISA (Agência Nacional de Vigilância Sanitária) to initiate a global Phase 3 efficacy trial for INO-4800, its DNA vaccine candidate for COVID-19.
Artiva Biotherapeutics Announces New San Diego Facility
BIOTECH: R&D and GMP Manufacturing Center to Open in 2022
Artiva Biotherapeutics, a clinical-stage biotech company developing off-the-shelf, allogeneic, natural killer (NK) cell-based therapies, will establish a 52,000 square foot research and manufacturing center at its San Diego headquarters.
ResMed Reports $3.2 Billion in Revenue
BIOTECH: Demand Growing; New Product Launched
ResMed, the leading global manufacturer in sleep apnea therapy, reported their Q4 earnings on Aug. 5 and recorded $876.1 million in revenue.
Prev Next